Sinovac Biotech Ltd
NASDAQ:SVA

Watchlist Manager
Sinovac Biotech Ltd Logo
Sinovac Biotech Ltd
NASDAQ:SVA
Watchlist
Price: 6.47 USD Market Closed
Market Cap: $644.7m

Wall Street
Price Targets

SVA Price Targets Summary
Sinovac Biotech Ltd

There are no price targets for SVA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Sinovac Biotech Ltd Competitors:
Price Targets
APA
APA Corp (US)
1% Upside
CASY
Caseys General Stores Inc
0% Downside
AKTIA
Aktia Bank Abp
-7% Downside
KNSA
Kiniksa Pharmaceuticals Ltd
33% Upside
PTEN
Patterson-UTI Energy Inc
-1% Downside
QXO
SilverSun Technologies Inc
37% Upside

Revenue
Forecast

22% / Year
Past Growth
-20% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat
22% / Year
Past Growth
-20% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

For the last 13 years the compound annual growth rate for Sinovac Biotech Ltd's revenue is 22%. The projected CAGR for the next 9 years is -20%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-34%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-34%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SVA's stock price target?
Not Available

SVA doesn't have any price targets made by Wall Street professionals.

What is Sinovac Biotech Ltd's Revenue forecast?
Projected CAGR
-20%

For the last 13 years the compound annual growth rate for Sinovac Biotech Ltd's revenue is 22%. The projected CAGR for the next 9 years is -20%.

Back to Top